Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.
Summary
This study identifies PITTs as proinflammatory platelet membrane structures that anchor to leukocytes/endothelium, promoting leukocyte activation and vascular inflammation. In mouse infection/endotoxemia models, αIIbβ3 blockade reduced immune-mediated tissue damage; in human sepsis/COVID-19, PITT formation and platelet αIIbβ3 loss correlated with disease severity.
Key Findings
- Flow-triggered αIIbβ3 ligation induces PITTs that tether to leukocytes/endothelium while platelet bodies detach.
- PITTs promote leukocyte activation and vascular inflammation in mouse infection/endotoxemia models.
- αIIbβ3 blockade reduces immune-mediated tissue damage in vivo.
- In patients with sepsis/COVID-19/severe infection, higher PITT formation and αIIbβ3 loss correlate with worse outcomes.
Clinical Implications
αIIbβ3 antagonism or strategies that prevent PITT formation may attenuate thrombo-inflammation in sepsis. PITT levels could serve as biomarkers for risk stratification and therapeutic monitoring.
Why It Matters
Reveals a previously unrecognized platelet-derived inflammatory structure linking thrombosis and inflammation with direct relevance to sepsis severity, suggesting αIIbβ3/PITT as a therapeutic axis.
Limitations
- Clinical cohorts are correlative; causality in humans remains to be established.
- Potential bleeding risks with αIIbβ3 blockade require careful translational consideration.
Future Directions
Prospective human studies to validate PITTs as biomarkers; interventional trials of αIIbβ3/PITT-targeted therapies; deeper characterization of PITT composition and clearance.
Study Information
- Study Type
- Cohort
- Research Domain
- Pathophysiology
- Evidence Level
- III - Mechanistic experimental study with supportive human observational cohort correlations; no randomized intervention.
- Study Design
- OTHER